The Latest Breaking News on Pharma

The pharmacy chain failed to properly investigate suspicious opioid orders, according to federal ruling

Gilead Sciences (GILD), a biopharmaceutical company, reported strong demand across its HIV portfolio and raised its full-year guidance. Given the company’s robust profitability and discounted valuation, we think it could be wise to buy the stock now. Read on….

The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to Relmada Therapeutics’ (NASDAQ:RLMD) lead asset REL-1017 as a monotherapy for the treatment major depressive disorder (MDD). Relmada shares traded in a range of $26.02 to $27.96 on a day volume of 173.79 thousand shares, closed regular trading…

Drugmaker Gilead Sciences plans to announce on Tuesday that it will provide up to $5 million in grants to help a coalition of LGBTQ+ and human rights advocacy groups craft public health responses to monkeypox outbreaks, the company said.

Pharmaceutical pricing authority discussed issue in 2019, show documents

Four French pharmacies will be authorised to vaccinate against monkeypox from Wednesday, according to the office of Health Minister François Braun.

Pharmaceutical giant Pfizer is facing calls to improve its pay offer to manufacturing employees in Perth, who have walked off the job.

The only Lyme disease vaccine previously marketed in the U.S. was discontinued in 2002.

The pharmaceutical industry is growing rapidly with advancements in drug manufacturing and a paradigm shift to personalized medicines. Moreover, despite soaring prices, supportive fiscal policies are expected to keep consumer demand stable. Quality pharmaceutical stocks Pfizer (PFE) and Merck (MRK) have outperformed the broader market over the past year and…